| Thomas M Skeehan, MD | |
|
3399 Trindle Rd, Camp Hill, PA 17011 | |
| (717) 761-5530 | |
| (717) 737-7197 |
| Full Name | Thomas M Skeehan |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 41 Years |
| Location | 3399 Trindle Rd, Camp Hill, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407856339 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207LP2900X | Anesthesiology - Pain Medicine | MD-032527-E (Pennsylvania) | Secondary |
| 207L00000X | Anesthesiology | MD032527E (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopedic Surgeons Ltd | 4385535244 | 86 |
News Archive
Obesity and dental cavities increase and become epidemic as children living below the poverty level age, according to nurse researchers from the Case Western Reserve University and the University of Akron.
Surgical Risk Solutions, LLC announced today the introduction of a unique new insurance product designed to provide financial resources to surgical patients in the event that they have adverse outcomes following surgery.
Intra-Cellular Therapies, Inc. ("ITI") and Takeda Pharmaceutical Company Limited, today announced that they have entered into an exclusive collaboration to develop and commercialize selective phosphodiesterase type 1 (PDE1) inhibitors, discovered by ITI, for the treatment of cognitive impairment associated with schizophrenia. This agreement is targeted worldwide, but ITI has retained the option to co-promote with Takeda in the United States.
Public Campaign Action Fund raised serious conflict of interest questions about Rep. Charles Boustany (R-La.) and the expected opposing remarks he will deliver tonight in response to President Barack Obama's speech to a joint session of Congress on health care reform.
› Verified 7 days ago
| Entity Name | Orthopedic Surgeons Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386620755 PECOS PAC ID: 4385535244 Enrollment ID: O20040322001130 |
News Archive
Obesity and dental cavities increase and become epidemic as children living below the poverty level age, according to nurse researchers from the Case Western Reserve University and the University of Akron.
Surgical Risk Solutions, LLC announced today the introduction of a unique new insurance product designed to provide financial resources to surgical patients in the event that they have adverse outcomes following surgery.
Intra-Cellular Therapies, Inc. ("ITI") and Takeda Pharmaceutical Company Limited, today announced that they have entered into an exclusive collaboration to develop and commercialize selective phosphodiesterase type 1 (PDE1) inhibitors, discovered by ITI, for the treatment of cognitive impairment associated with schizophrenia. This agreement is targeted worldwide, but ITI has retained the option to co-promote with Takeda in the United States.
Public Campaign Action Fund raised serious conflict of interest questions about Rep. Charles Boustany (R-La.) and the expected opposing remarks he will deliver tonight in response to President Barack Obama's speech to a joint session of Congress on health care reform.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas M Skeehan, MD 3399 Trindle Rd, Camp Hill, PA 17011-4407 Ph: (717) 761-5530 | Thomas M Skeehan, MD 3399 Trindle Rd, Camp Hill, PA 17011 Ph: (717) 761-5530 |
News Archive
Obesity and dental cavities increase and become epidemic as children living below the poverty level age, according to nurse researchers from the Case Western Reserve University and the University of Akron.
Surgical Risk Solutions, LLC announced today the introduction of a unique new insurance product designed to provide financial resources to surgical patients in the event that they have adverse outcomes following surgery.
Intra-Cellular Therapies, Inc. ("ITI") and Takeda Pharmaceutical Company Limited, today announced that they have entered into an exclusive collaboration to develop and commercialize selective phosphodiesterase type 1 (PDE1) inhibitors, discovered by ITI, for the treatment of cognitive impairment associated with schizophrenia. This agreement is targeted worldwide, but ITI has retained the option to co-promote with Takeda in the United States.
Public Campaign Action Fund raised serious conflict of interest questions about Rep. Charles Boustany (R-La.) and the expected opposing remarks he will deliver tonight in response to President Barack Obama's speech to a joint session of Congress on health care reform.
› Verified 7 days ago
Ji Min, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 503 N 21st St, Camp Hill, PA 17011 Phone: 717-763-2126 Fax: 717-975-0779 | |
Robert A Goodman, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 503 N 21st St, Camp Hill, PA 17011 Phone: 717-763-2126 Fax: 717-975-0779 | |
Taryn Michelle Reichard, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3399 Trindle Rd, Camp Hill, PA 17011 Phone: 717-761-5530 Fax: 717-737-7197 | |
Jonathan A Anson, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 501 N. 21st Street, Camp Hill, PA 17011 Phone: 717-763-2126 Fax: 717-975-0779 | |
Glenn Carnicelli, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 503 N 21st St, Camp Hill, PA 17011 Phone: 717-763-2126 | |
Neelima M Parikh, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 503 N 21st St, Camp Hill, PA 17011 Phone: 717-763-2126 Fax: 717-975-0779 | |
James A. Pastor, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 503 N 21st St, Camp Hill, PA 17011 Phone: 717-763-2126 Fax: 717-975-0779 |